Cargando…
PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430294/ http://dx.doi.org/10.1097/01.HS9.0000974372.45108.8e |
| _version_ | 1785090928538550272 |
|---|---|
| author | Montesinos, Pau Al-Ali, Haifa Kathrin Dominguez, Juan Manuel Alonso Jentzsch, Madlen Lavrencic, Mojca Martelli, Maria Paola Röllig, Christoph Sica, Simona Riham, Iadevaia Yablonski, Kaitlin Wang, Tianli Mahmood, Zafar Koenen, Giedre Schmidt, Hank Yang, Jingsing Yee, Karen |
| author_facet | Montesinos, Pau Al-Ali, Haifa Kathrin Dominguez, Juan Manuel Alonso Jentzsch, Madlen Lavrencic, Mojca Martelli, Maria Paola Röllig, Christoph Sica, Simona Riham, Iadevaia Yablonski, Kaitlin Wang, Tianli Mahmood, Zafar Koenen, Giedre Schmidt, Hank Yang, Jingsing Yee, Karen |
| author_sort | Montesinos, Pau |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430294 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104302942023-08-17 PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 Montesinos, Pau Al-Ali, Haifa Kathrin Dominguez, Juan Manuel Alonso Jentzsch, Madlen Lavrencic, Mojca Martelli, Maria Paola Röllig, Christoph Sica, Simona Riham, Iadevaia Yablonski, Kaitlin Wang, Tianli Mahmood, Zafar Koenen, Giedre Schmidt, Hank Yang, Jingsing Yee, Karen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430294/ http://dx.doi.org/10.1097/01.HS9.0000974372.45108.8e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Montesinos, Pau Al-Ali, Haifa Kathrin Dominguez, Juan Manuel Alonso Jentzsch, Madlen Lavrencic, Mojca Martelli, Maria Paola Röllig, Christoph Sica, Simona Riham, Iadevaia Yablonski, Kaitlin Wang, Tianli Mahmood, Zafar Koenen, Giedre Schmidt, Hank Yang, Jingsing Yee, Karen PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 |
| title | PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 |
| title_full | PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 |
| title_fullStr | PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 |
| title_full_unstemmed | PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 |
| title_short | PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417 |
| title_sort | pb1887: sting agonist for the treatment of relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a first-in-clinic phase 1 study of gsk3745417 |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430294/ http://dx.doi.org/10.1097/01.HS9.0000974372.45108.8e |
| work_keys_str_mv | AT montesinospau pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT alalihaifakathrin pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT dominguezjuanmanuelalonso pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT jentzschmadlen pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT lavrencicmojca pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT martellimariapaola pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT rolligchristoph pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT sicasimona pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT rihamiadevaia pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT yablonskikaitlin pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT wangtianli pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT mahmoodzafar pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT koenengiedre pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT schmidthank pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT yangjingsing pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 AT yeekaren pb1887stingagonistforthetreatmentofrelapsedrefractoryacutemyeloidleukemiaandhighriskmyelodysplasticsyndromeafirstinclinicphase1studyofgsk3745417 |